Trials / Terminated
TerminatedNCT01755208
Light-Scattering Spectroscopy for Detection of Breast Cancer
Light-Scattering Spectroscopy for the Detection of Stage II-III Breast Cancer: A Pilot Study
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 110 (actual)
- Sponsor
- University of Southern California · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This pilot clinical trial studies light-scattering spectroscopy in finding disease in patients with stage II-III breast cancer. Diagnostic procedures, such as light-scattering spectroscopy, may help find and diagnose breast cancer
Detailed description
PRIMARY OBJECTIVES: I. To evaluate whether light-scattering spectroscopy can reliably distinguish between two subject groups: those with clinical stage II or stage III breast cancer and those without breast cancer. OUTLINE: Patients undergo light-scattering spectroscopy of the breast in addition to standard of care as it relates to screening for breast cancer or treatment of breast cancer.
Conditions
- Healthy, no Evidence of Disease
- Stage II Breast Cancer
- Stage IIIA Breast Cancer
- Stage IIIB Breast Cancer
- Stage IIIC Breast Cancer
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | light-scattering spectroscopy | Undergo light-scattering spectroscopy |
Timeline
- Start date
- 2012-11-21
- Primary completion
- 2020-11-19
- Completion
- 2020-11-19
- First posted
- 2012-12-24
- Last updated
- 2021-11-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01755208. Inclusion in this directory is not an endorsement.